XML 38 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Collaboration Agreements - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Apr. 30, 2020
Dec. 31, 2019
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Revenue recognized $ 966,000 $ 1,528,000 $ 3,057,000 $ 3,740,000      
Collaboration and License Agreement | Hanmi Pharmaceutical Co., LTD              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Upfront and near-term milestone payment 10,400,000   10,400,000       $ 10,000,000.0
Upfront fee 4,000,000.0   4,000,000.0       4,000,000.0
Milestone payment 6,000,000.0   6,000,000.0     $ 6,000,000.0  
Milestone payment related to supply 400,000   400,000        
Revenue recognized 1,000,000.0   3,100,000        
Deferred revenue $ 2,300,000   $ 2,300,000   $ 5,000,000.0    
Collaboration and License Agreement | Hanmi Pharmaceutical Co., LTD | Maximum              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Contingent payments upon achievement of specified milestones             $ 108,000,000.0